Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation

Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer

(2011) V. Padler-Karavani et al.   CANCER RESEARCH

Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases

(2011) Tingting Yue et al.   PROTEOMICS

CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer

(2011) Victor Molina et al.   TUMOR BIOLOGY

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

(2010) S. Boeck et al.   CLINICAL CANCER RESEARCH

Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells

(2010) S. Inoue et al.   GLYCOBIOLOGY

Shotgun glycomics: a microarray strategy for functional glycomics

(2010) Xuezheng Song et al.   NATURE METHODS

Microarrays in Glycoproteomics Research

(2009) Tingting Yue et al.   CLINICS IN LABORATORY MEDICINE

A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins

(2009) Andrew Porter et al.   GLYCOBIOLOGY

Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma

(2009) Joshua G. Barton et al.   JOURNAL OF GASTROINTESTINAL SURGERY

The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Lectin Sandwich Arrays

(2009) Tingting Yue et al.   MOLECULAR & CELLULAR PROTEOMICS

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

(2008) Viviane Hess et al.   LANCET ONCOLOGY